Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation. Clin Interv Aging (2013) 0.81

Anticoagulation Stability Depends on CHADS2 Score and Hepatorenal Function in Warfarin-treated Patients, Including Those with Atrial Fibrillation. J Atheroscler Thromb (2016) 0.75

The economic burden of ischemic stroke and major hemorrhage in medicare beneficiaries with nonvalvular atrial fibrillation: a retrospective claims analysis. Am Health Drug Benefits (2014) 0.75

Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation. J Atr Fibrillation (2016) 0.75

Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA (2001) 24.12

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest (2009) 14.06

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med (1994) 10.26

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet (2007) 10.10

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet (2006) 9.43

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med (2003) 6.70

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med (2009) 4.71

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13

Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med (2010) 4.01

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing (2006) 3.40

Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ (2007) 3.30

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 3.11

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J (2006) 3.05

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation (2008) 2.98

Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ (2006) 2.71

Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation (2011) 2.60

Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology (2007) 2.16

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med (1999) 2.07

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke (2008) 2.06

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87

Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke (2005) 1.85

Status of the epidemiology of atrial fibrillation. Med Clin North Am (2008) 1.80

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM (2007) 1.76

Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke (2008) 1.71

Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res (2005) 1.71

Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging (2010) 1.69

Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med (2005) 1.61

Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation. Heart (2011) 1.54

Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing (2004) 1.50

Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke (2001) 1.49

Impact of new criteria for anticoagulant treatment in atrial fibrillation. Rev Esp Cardiol (2011) 1.44

Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med (2006) 1.40

Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med (2004) 1.36

Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation. Stroke (2010) 1.33

Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke (2004) 1.23

Preventing stroke in patients with atrial fibrillation. JAMA (1999) 1.22

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med (2007) 1.08

The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health (2008) 1.08

Major bleeding complications in a specialized anticoagulation service. Am J Cardiol (2005) 1.03

Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother (2008) 1.02

Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J (2011) 0.98

Update on atrial fibrillation: part I. Clin Cardiol (2008) 0.97

Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 0.96

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial. BMJ (2011) 0.90

Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic. Clin Ther (2004) 0.89

The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. Value Health (2008) 0.89

The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy. Thromb J (2005) 0.88

Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy. J Thromb Haemost (2010) 0.85

Quality of life of elderly people on warfarin for atrial fibrillation. Age Ageing (2009) 0.81

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation. Stroke (2011) 0.80

Use of resources and cost implications of stroke prophylaxis with warfarin for patients with nonvalvular atrial fibrillation. Am J Geriatr Pharmacother (2003) 0.79

Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study. Stroke (2011) 0.79

Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Blood Coagul Fibrinolysis (2009) 0.76

Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. Europace (2010) 0.76

Chronic kidney disease in older people; disease or dilemma? Saudi J Kidney Dis Transpl (2010) 1.52

Are recurrent fallers depressed? J Am Geriatr Soc (2007) 1.43

Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci (2003) 1.23

Evaluation of an isothermal signal amplification method for rapid detection of methicillin-resistant Staphylococcus aureus from patient-screening swabs. J Clin Microbiol (2003) 0.84

The U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life. Aging Dis (2012) 0.83

Use of multicompartment compliance aids for elderly patients: patient viewpoints and hospital length of stay. Postgrad Med (2010) 0.83

Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis. Age Ageing (2012) 0.79

Routinely assessed biochemical markers tested on admission as predictors of adverse outcomes in hospitalized elderly patients. Hosp Pract (1995) (2012) 0.77

Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes. Postgrad Med (2009) 0.76

Prevalence and determinants of anemia in older people with diabetes attending an outpatient clinic: a cross-sectional audit. Clin Diabetes (2014) 0.76

Effect of diabetes service for older people on length of hospital stay. J Am Geriatr Soc (2008) 0.75

Clinical assessment of symptomatic osteoarthritis in older people. Age Ageing (2003) 0.75

Delayed discharges due to initiation of warfarin in atrial fibrillation: a prospective audit. Am J Geriatr Pharmacother (2007) 0.75

An unusual cause of 'pleuritic' chest pain. Acute Med (2008) 0.75

Frailty predicts adverse outcomes in older people with diabetes. Practitioner (2017) 0.75

Anticoagulation of atrial fibrillation in older people: a clinical practice observational study. J Am Geriatr Soc (2006) 0.75